Posttraumatic Stress Disorder (PTSD) Clinical Trial
Official title:
Progression and Remittance of Traumatic Stress-related Symptoms During and After Narrative Exposure Therapy
Narrative Exposure Therapy (NET) has been proven to be effective in the treatment of
Posttraumatic Stress Disorder (PTSD) and trauma-related depression in more than a dozen
controlled clinical trials. Symptom reduction was greatest during long-term follow-ups after
the completion of the therapy.
In the current study, we will investigate the progression of PTSD symptoms and emotional
stress before, during and after therapy. After a semi-structured interview all participants
will be asked to report in monthly telephone interviews their core symptoms. Structured
interviews after 6 and 12 months are used to validate the outcome. A convenience sample of
individuals with a PTSD will be offered participation in the study.
Participants will be recruited through the Center of Excellence for Psychotraumatology,
University of Konstanz, with focus on refugees. All of them (approx. 100) will receive a
structured interview and a detailed diagnosis. The interview includes questions about
sociodemography, traumatic events, PTSD and depression symptomatology. Individuals with a
PTSD diagnosis (up to 30) will be offered a Narrative Exposure Therapy (NET).
Irrespective of treatment and diagnosis, respondents are asked to participate in monthly
telephone interviews assessing trauma-related and emotional distress and changes in life.
Interviews assessing PTSD, depression symptoms and emotional distress will be conducted 6 and
12 months after the initial interview.
In addition, participants receiving NET will rate their PTSD symptoms and functionality prior
to each therapy session.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01443182 -
Treatment of Posttraumatic Stress Disorder (PTSD) in Adult Survivors of Early Chronic Interpersonal Trauma
|
N/A | |
Completed |
NCT01507948 -
Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT02911285 -
NAC for Treating Comorbid PTSD and SUD
|
Phase 2 | |
Recruiting |
NCT02234076 -
A Study on the Efficacy of Virtual Reality Exposure Therapy (VRET) for Survivors of Childhood Sexual Abuse and War Related Trauma
|
N/A | |
Completed |
NCT01729026 -
A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD)
|
Early Phase 1 | |
Completed |
NCT01406834 -
Treatment for the Mental Health Impact of Killing in War
|
N/A | |
Completed |
NCT01464892 -
Imagery Rescripting in the Treatment of Post Traumatic Stress Disorder (PTSD) Following Early Chronic Interpersonal Trauma
|
N/A | |
Completed |
NCT01446146 -
Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice
|
N/A | |
Active, not recruiting |
NCT03283163 -
Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD
|
N/A | |
Completed |
NCT02442843 -
Non Invasive Brain Stimulation for PTSD
|
Early Phase 1 | |
Completed |
NCT01888653 -
Attention-Bias Modification Treatment for PTSD
|
N/A | |
Completed |
NCT01474057 -
DElivery of Self Training and Education for Stressful Situations-Primary Care Version
|
Phase 2 | |
Completed |
NCT00672776 -
Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)
|
Phase 4 | |
Completed |
NCT03641924 -
Cognition and Psychotherapy in PTSD
|
||
Completed |
NCT02397889 -
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)
|
Phase 2/Phase 3 | |
Completed |
NCT02322047 -
Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
|
Phase 2 | |
Completed |
NCT00320138 -
Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel
|
Phase 1 | |
Recruiting |
NCT03833453 -
Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD
|
N/A | |
Completed |
NCT03833531 -
Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD
|
N/A | |
Completed |
NCT03529435 -
Project Remission: Maximizing Outcomes With Intensive Treatments for Combat-Related PTSD
|
N/A |